NLTX - Neoleukin Therapeutics Inc. (NLTX) CEO Jonathan Drachman on Q4 2021 Results - Earnings Call Transcript

Neoleukin Therapeutics, Inc. (NLTX) Q4 2021 Earnings Conference Call March 1, 2022 4:30 PM ET Company Participants Julie Rathbun - Communications, Investor Relations Jonathan Drachman - CEO Priti Patel - CMO Sean Smith - Vice President, Finance Conference Call Participants Mary Kate - Bank of America Joe Catanzaro - Piper Sandler Charles Zhu - Guggenheim Mara Goldstein - Mizuho Presentation Operator Good afternoon and thank you for joining us today for Neoleukin Therapeutics Conference Call. At this time, all participants are in listen-only mode. Following the conclusion of the prepared remarks, we will conduct a question-and-answer session, and instructions will follow at that time. As a reminder, today’s conference call is being recorded. I would now like to turn the call over to Julie Rathbun, Communications for Neoleukin Therapeutics. Julie, please go ahead. Julie Rathbun Thank you. Good afternoon and welcome to Neoleukin Therapeutics year end 2021 conference call. Joining

For further details see:

Neoleukin Therapeutics, Inc. (NLTX) CEO Jonathan Drachman on Q4 2021 Results - Earnings Call Transcript